Rodolphe Fischmeister

Rodolphe Fischmeister serves as Director of Research INSERM 'Classe Exceptionnelle' at University of Paris-Sud, holding dual leadership roles as Head of Laboratory INSERM UMR-S 1180 (Laboratoire de Signalisation et Physiopathologie Cardiovasculaire) and Head of Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LabEx LERMIT) within the Faculty of Pharmacy. His career spans over four decades with continuous progression through INSERM research ranks since 1983, including founding leadership of major research institutes IFR75 (1998-2001) and IFR141 (2006-2010).

Dr. Fischmeister's research focuses on fundamental cardiac mechanisms, particularly neuroendocrine regulation of heart function, cyclic nucleotide signaling pathways, and molecular pharmacology of cardiac ion channels. His work integrates membrane physiology with cardiovascular pharmacology to investigate cellular control systems in cardiac electrophysiology, with emphasis on intracellular compartmentation and ionic channel dynamics. This multidisciplinary approach bridges basic science with therapeutic innovation in cardiovascular medicine.

• Member of Academia Europaea (2007)
• Jeanne-Philippe Beziat Cardiology Prize (2012)
• Alain Castaigne Prize (2014)
• Brutsaert Lecturer, European Society of Cardiology (2010)
• FISHR Fellow, International Society for Heart Research (2013)
• Nobel Prize nomination privilege (2010-)

As an academic leader, Fischmeister has served on multiple national research councils including University Paris-Sud Research Council (2001-2004) and Faculty of Pharmacy Research Council (1998-2001). His editorial contributions include Associate Editor for Cardiovascular Research (2013-) and previous editorships at Journal of Physiology and British Journal of Pharmacology. He directs LabEx LERMIT, a major research initiative focused on translating fundamental discoveries into innovative therapeutics.